Observed Characteristics Associated with Diabetes Device Use Among Teens with Type 1 Diabetes
Overview
Affiliations
Background: Despite advancements in diabetes technologies, disparities remain with respect to diabetes device use in youth with type 1 diabetes (T1D). We compared sociodemographic, diabetes, and psychosocial characteristics associated with device (pump and continuous glucose monitor [CGM]) use in 13- to 17-year-old teens with T1D.
Materials/methods: Data were derived from a multicenter clinical trial to optimize self-care and glycemic control in teens with T1D. We categorized teens as pump users versus non-users and CGM users versus non-users based on their diabetes device usage. Chi-square and -tests compared characteristics according to device use.
Results: The sample comprised 301 teens (50% female) with baseline mean ± SD age 15.0 ± 1.3 years, T1D duration 6.5 ± 3.7 years, and HbA1c 8.5 ± 1.1% (69 ± 12 mmol/mol). Two-thirds (65%) were pump users, and 27% were CGM users. Pump users and CGM users (vs. non-users) were more likely to have a family annual household income ≥$150,000, private health insurance, and a parent with a college education (all < .001). Pump users and CGM users (vs. non-users) also performed more frequent daily blood glucose (BG) checks (both < .001) and reported more diabetes self-care behaviors (both < .05). Pump users were less likely to have baseline HbA1c ≥9% (75 mmol/mol) ( = .005) and to report fewer depressive symptoms ( = .02) than pump non-users. Parents of both CGM and pump users reported a higher quality of life in their youth ( < .05).
Conclusion: There were many sociodemographic, diabetes-specific, and psychosocial factors associated with device use. Modifiable factors can serve as the target for clinical interventions; youth with non-modifiable factors can receive extra support to overcome potential barriers to device use.
de Bock M, Agwu J, Deabreu M, Dovc K, Maahs D, Marcovecchio M Horm Res Paediatr. 2024; 97(6):546-554.
PMID: 39701064 PMC: 11854972. DOI: 10.1159/000543266.
Biester T, Berget C, Boughton C, Cudizio L, Ekhlaspour L, Hilliard M Horm Res Paediatr. 2024; 97(6):636-662.
PMID: 39657603 PMC: 11854989. DOI: 10.1159/000543034.
Morrow E, Spieker A, Greevy R, Roddy M, Mayberry L J Gen Intern Med. 2024; .
PMID: 39455481 DOI: 10.1007/s11606-024-09101-1.
Chen C, Serata E, Scheub R, Dassau T, Wasserman R, Anderson B Diabetes Res Clin Pract. 2024; 212():111719.
PMID: 38789009 PMC: 11736807. DOI: 10.1016/j.diabres.2024.111719.
Been R, Lameijer A, Gans R, van Beek A, Kingsnorth A, Choudhary P Ther Adv Endocrinol Metab. 2024; 15:20420188241236289.
PMID: 38476216 PMC: 10929059. DOI: 10.1177/20420188241236289.